Posts by Sandra Ansanay-Alex
ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in Geneva Switzerland, developing novel therapies for women’s health, today announced the sale of all of the Company’s rights to Ebopiprant to XOMA Corporation (XOMA) for an upfront payment of $15 million and future milestone payments…
Read MoreOpna Bio Raises $38M in Series A Financing
Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round was led by Longitude Capital and Northpond Ventures, with participation from Menlo Ventures. The proceeds will be used to develop novel fragile-X mental retardation protein (FMRP) inhibitors in oncology as well as a diverse…
Read MoreClaude Nicollier steps down from his position as CSEM
The former astronaut has spent 16 years as Chairperson of the Board of Directors Effective June 2023, Claude Nicollier will step down from his position as CSEM’s Chairperson of the Board of Directors during its Annual General Meeting. “CSEM is well-prepared for the future, meaning I can pass the baton over next year with…
Read MoreNovigenix announces first closing of its $20M Series B
The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient stratification and monitoring of Immunotherapies. Novigenix SA, a leading data-driven precision medicine biotech based in Biopôle Lausanne, that develops and commercializes Immuno-Transcriptomic precision oncology solutions, today announced a successful first closing of its $20…
Read MoreNeuria receives the Start-Up Innovation Prize of the Canton of Fribourg
Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders On 9 November 2022, was organised the Innovation Prize Ceremony of the Canton of Fribourg. Neuria received the most votes. The winning start-up was chosen by the jury and the public through a vote organised…
Read MoreA CHF 1.6 million Innosuisse Grant for PeriVision
PeriVision was awarded an Innosuisse research grant together with the University Hospital Bern and ARTORG Center for Biomedical Engineering Research to investigate remote visual field testing in glaucoma patients. Glaucoma is one of the leading causes of blindness around the world and is a chronic condition that needs continuous monitoring. It affects c. 2%…
Read MoreMICROCITY Neuchâtel, Land of Diagnostic
A Human lean Diagnostic programme in the canton of precision watchmaking The historical heritage of high precision and core competencies in micro and nanotechnologies (micromechanics, microelectronics, advanced manufacturing) as well as its unique expertise in miniaturization, ultra-low energy consumption, reliability and complexity mean that the canton of Neuchâtel can connect all the competencies necessary…
Read MoreDomo Health and Roche develop a digital health solution to detect the first signs of respiratory infections
Domo Health, a leader in digital health, announced the launch of its clinical study in collaboration with Roche Pharma Suisse SA, that aims to develop a digital health solution detecting hypoventilation and warning signs of respiratory infections. The adoption of new digital health technologies is accelerating globally. Thanks to digital health solutions, it is…
Read MoreDebiopharm leads $6M round for YonaLink to Scale Global Growth
The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and costs Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software provider, announced having completed an initial funding round, raising $6 million, to scale global…
Read MoreBone marrow neurons can be rewired to enable paraplegics to walk
Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system with the capacity to change function A new study by scientists at the .NeuroRestore research center has identified the type of neuron that is activated and remodeled by spinal cord stimulation, allowing patients to…
Read More